Functional Decline Predicts Emergency Department Use in Veterans With Dementia.

Background: We examined emergency room (ER) utilization by persons with dementia (PWDs) using caregiver and patient characteristics as predictors.

Methods: A secondary analysis of 296 veteran-caregiver dyads. Caregivers recorded PWD baseline characteristics and noted ER visits over the next year.

Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.

Purpose: The purpose of this study was to compare brain and tumor signal characteristics of T1-weighted turbo spin-echo (TSE) and gradient recalled echo (GRE) sequence techniques at 3 T compared to TSE at 1.5 T, focusing on the detection of contrast enhancement, in a standardized animal model of a brain glioma.

Materials And Methods: Twelve rats with implanted brain gliomas were evaluated at 1.

Brain magnetic resonance imaging at 3 Tesla using BLADE compared with standard rectilinear data sampling.

Objectives: We sought to evaluate Periodically Rotated Overlapping ParallEL Lines with Enhanced Reconstruction (PROPELLER; BLADE) data acquisition in comparison with standard k-space sampling techniques for axial and sagittal brain imaging at 3 T regarding imaging artifacts.

Material And Methods: Forty patients who gave consent were included in a prospective comparison of standard and PROPELLER (BLADE) k-space sampling techniques. All examinations were performed at 3 T with comparison of standard T2-weighted fluid-attenuated inversion recovery (FLAIR) to PROPELLER T2-weighted FLAIR in the axial image orientation and standard T1-weighted gradient echo to PROPELLER T1-weighted FLAIR in the sagittal image orientation.

The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.

Objectives: The objectives of this study were to analyze the differences in contrast enhancement using gadobenate dimeglumine (Gd-BOPTA or MultiHance) at 3 T versus 1.5 T and to compare Gd-BOPTA with a standard gadolinium chelate, gadopentetate dimeglumine (Gd-DTPA or Magnevist), at 3 T in a rat glioma model.

Materials And Methods: Twelve rats with surgically implanted gliomas were randomized to either comparing Gd-BOPTA at 1.

Brain tumor enhancement in magnetic resonance imaging: comparison of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) at 1.5 versus 3 tesla.

Objective: The objective of this study was to compare the difference in lesion enhancement between 1.5 and 3 T using an extracellular gadolinium chelate in a rat brain glioma model.

Methods: Five rats (CDF Fischer 344) with implanted C6/LacZ brain gliomas were evaluated using matched T1-weighted spin echo techniques and hardware configurations at 1.